ATE480533T1 - Variolinderivate und ihre verwendung als cytostatika - Google Patents
Variolinderivate und ihre verwendung als cytostatikaInfo
- Publication number
- ATE480533T1 ATE480533T1 AT07013582T AT07013582T ATE480533T1 AT E480533 T1 ATE480533 T1 AT E480533T1 AT 07013582 T AT07013582 T AT 07013582T AT 07013582 T AT07013582 T AT 07013582T AT E480533 T1 ATE480533 T1 AT E480533T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- derivatives
- unsubstituted
- varioline
- cytostatics
- Prior art date
Links
- 239000000824 cytostatic agent Substances 0.000 title 1
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 abstract 2
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 229930186114 Variolin Natural products 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Carbon And Carbon Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0116966.3A GB0116966D0 (en) | 2001-07-11 | 2001-07-11 | Anittumoral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE480533T1 true ATE480533T1 (de) | 2010-09-15 |
Family
ID=9918335
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02745614T ATE396987T1 (de) | 2001-07-11 | 2002-07-11 | Variolinderivate und ihre verwendung als cytostatika |
| AT07013582T ATE480533T1 (de) | 2001-07-11 | 2002-07-11 | Variolinderivate und ihre verwendung als cytostatika |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02745614T ATE396987T1 (de) | 2001-07-11 | 2002-07-11 | Variolinderivate und ihre verwendung als cytostatika |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7495000B2 (de) |
| EP (2) | EP1404668B1 (de) |
| JP (1) | JP4369225B2 (de) |
| KR (1) | KR100929616B1 (de) |
| CN (1) | CN1553906B (de) |
| AT (2) | ATE396987T1 (de) |
| AU (1) | AU2002317329B2 (de) |
| CA (1) | CA2453418C (de) |
| DE (2) | DE60226869D1 (de) |
| ES (2) | ES2354991T3 (de) |
| GB (1) | GB0116966D0 (de) |
| HU (1) | HUP0402658A2 (de) |
| IL (2) | IL159792A0 (de) |
| MX (1) | MXPA04000355A (de) |
| NO (1) | NO328848B1 (de) |
| NZ (1) | NZ530556A (de) |
| PL (1) | PL366894A1 (de) |
| RU (1) | RU2302419C2 (de) |
| WO (1) | WO2003006457A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001270783B2 (en) | 2000-07-11 | 2006-06-15 | Pharma Mar, S.A. | Variolin derivatives as anti-cancer agents |
| GB0019117D0 (en) * | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
| GB0116966D0 (en) | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
| AR072092A1 (es) * | 2008-06-11 | 2010-08-04 | Genentech Inc | Diazacarbazoles y metodos de uso |
| US11332480B2 (en) | 2017-04-27 | 2022-05-17 | Pharma Mar, S.A. | Antitumoral compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001270783B2 (en) * | 2000-07-11 | 2006-06-15 | Pharma Mar, S.A. | Variolin derivatives as anti-cancer agents |
| GB0019117D0 (en) * | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
| GB0116966D0 (en) | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
-
2001
- 2001-07-11 GB GBGB0116966.3A patent/GB0116966D0/en not_active Ceased
-
2002
- 2002-07-11 HU HU0402658A patent/HUP0402658A2/hu unknown
- 2002-07-11 WO PCT/GB2002/003197 patent/WO2003006457A1/en not_active Ceased
- 2002-07-11 CN CN028175298A patent/CN1553906B/zh not_active Expired - Fee Related
- 2002-07-11 DE DE60226869T patent/DE60226869D1/de not_active Expired - Lifetime
- 2002-07-11 EP EP02745614A patent/EP1404668B1/de not_active Expired - Lifetime
- 2002-07-11 PL PL02366894A patent/PL366894A1/xx not_active Application Discontinuation
- 2002-07-11 JP JP2003512229A patent/JP4369225B2/ja not_active Expired - Fee Related
- 2002-07-11 AT AT02745614T patent/ATE396987T1/de not_active IP Right Cessation
- 2002-07-11 KR KR1020047000500A patent/KR100929616B1/ko not_active Expired - Fee Related
- 2002-07-11 NZ NZ530556A patent/NZ530556A/en not_active IP Right Cessation
- 2002-07-11 IL IL15979202A patent/IL159792A0/xx unknown
- 2002-07-11 DE DE60237652T patent/DE60237652D1/de not_active Expired - Lifetime
- 2002-07-11 RU RU2004103857/04A patent/RU2302419C2/ru not_active IP Right Cessation
- 2002-07-11 AU AU2002317329A patent/AU2002317329B2/en not_active Ceased
- 2002-07-11 ES ES07013582T patent/ES2354991T3/es not_active Expired - Lifetime
- 2002-07-11 CA CA2453418A patent/CA2453418C/en not_active Expired - Fee Related
- 2002-07-11 MX MXPA04000355A patent/MXPA04000355A/es active IP Right Grant
- 2002-07-11 US US10/483,525 patent/US7495000B2/en not_active Expired - Fee Related
- 2002-07-11 EP EP07013582A patent/EP1867645B1/de not_active Expired - Lifetime
- 2002-07-11 ES ES02745614T patent/ES2307768T3/es not_active Expired - Lifetime
- 2002-07-11 AT AT07013582T patent/ATE480533T1/de not_active IP Right Cessation
-
2004
- 2004-01-11 IL IL159792A patent/IL159792A/en not_active IP Right Cessation
- 2004-01-12 NO NO20040113A patent/NO328848B1/no not_active IP Right Cessation
-
2009
- 2009-01-07 US US12/349,813 patent/US7772241B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE180468T1 (de) | Anthranilsäure derivate | |
| ATE141589T1 (de) | Alkoxyiminoacetamid-derivate und ihre verwendung als pilztötendes mittel | |
| DE69927039D1 (de) | Synthetische analoge des ecteinascidin-743 | |
| MXPA04001240A (es) | Analogos antitumorales. | |
| ATE117681T1 (de) | Chinolinderivate, ihre herstellung und verwendung. | |
| CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
| ATE88714T1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
| AU7769587A (en) | New compounds, processes for their preparation and their use | |
| DE3776044D1 (de) | Pyridazinon-derivate. | |
| ATE396987T1 (de) | Variolinderivate und ihre verwendung als cytostatika | |
| DE60138707D1 (de) | Variolinderivate als antikrebsmittel | |
| ATE207471T1 (de) | Dibenzo-oxazepin- und dioxepin-derivate und ihre verwendung als antitumormittel | |
| DE69624459D1 (de) | Kondensierte indan-derivate und ihre salze | |
| DE60116855D1 (de) | Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität | |
| DE60314426D1 (de) | Totalsynthese von myriaporonen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |